FDA-EMA Pilot Advice Scheme On Complex Generics Sees Slow Uptake
Two Applicants Have Completed The US-EU Parallel Advice Process So Far
While approaching the third year of its launch, the parallel advice program has seen a handful of applicants, but regulators on both sides of the Atlantic remain optimistic.
